Chinese General Practice ›› 2024, Vol. 27 ›› Issue (15): 1878-1885.DOI: 10.12114/j.issn.1007-9572.2023.0406
Special Issue: 心血管最新文章合辑; 老年人群健康最新文章合辑; 老年问题最新文章合辑; 中医最新文章合辑
• Original Research • Previous Articles Next Articles
Received:
2023-04-13
Revised:
2023-08-27
Published:
2024-05-20
Online:
2024-02-28
Contact:
YANG Xiaokun
通讯作者:
杨晓琨
作者简介:
基金资助:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.chinagp.net/EN/10.12114/j.issn.1007-9572.2023.0406
组别 | 例数 | 性别(男/女) | 年龄 | 吸烟史 | ASCVD家族史 | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|
65~69岁 | 70~74岁 | 75~79岁 | ≥80岁 | 有 | 无 | 有 | 无 | ||||
训练集 | 1 127 | 503/624 | 465(41.26) | 321(28.48) | 188(16.68) | 153(13.58) | 635(56.34) | 492(43.66) | 320(28.39) | 807(71.61) | |
验证集 | 291 | 138/153 | 129(44.33) | 65(22.34) | 56(19.24) | 41(14.09) | 166(57.05) | 125(42.96) | 89(30.58) | 202(69.42) | |
χ2值 | 0.73 | 4.66 | 0.05 | 0.54 | |||||||
P值 | 0.394 | 0.199 | 0.830 | 0.462 | |||||||
组别 | 糖尿病史 | 收缩压 | 高血压用药史 | 腰围 | |||||||
有 | 无 | <140 mmHg | ≥140 mmHg | 有 | 无 | 正常水平(男性<85 cm/女性<80 cm) | 升高(男性≥85 cm/女性≥80 cm) | ||||
训练集 | 344(30.52) | 783(69.48) | 737(65.39) | 390(34.61) | 633(56.17) | 494(43.83) | 251(22.27) | 876(77.73) | |||
验证集 | 84(28.87) | 207(71.13) | 188(64.61) | 103(35.39) | 167(57.39) | 124(42.61) | 65(22.34) | 226(77.66) | |||
χ2值 | 0.30 | 0.06 | 0.14 | 0.00 | |||||||
P值 | 0.583 | 0.801 | 0.708 | 0.981 | |||||||
组别 | BMI | TC | TG | ||||||||
低体质量(<18.5 kg/m2) | 正常体质量(18.5~23.9 kg/m2) | 超重(24.0~27.9 kg/m2) | 肥胖(≥28.0 kg/m2) | 合适水平(<5.2 mmol/L) | 边缘升高(5.2~<6.2 mmol/L) | 升高(≥6.2 mmol/L) | 合适水平(<1.7 mmol/L) | 边缘升高(1.7~<2.3 mmol/L) | 升高(≥2.3 mmol/L) | ||
训练集 | 377(33.45) | 443(39.31) | 297(26.35) | 10(0.89) | 589(52.26) | 391(34.69) | 147(13.04) | 756(67.08) | 206(18.28) | 165(14.64) | |
验证集 | 89(30.58) | 132(45.36) | 66(22.68) | 4(1.38) | 146(50.17) | 113(38.83) | 32(11.00) | 191(65.64) | 55(18.90) | 45(15.46) | |
χ2值 | 4.44 | 2.08 | 0.23 | ||||||||
P值 | 0.217 | 0.354 | 0.893 | ||||||||
组别 | 体质类型 | ASCVD事件 | |||||||||
平和质 | 气虚质 | 气郁质 | 湿热质 | 特禀质 | 痰湿质 | 血瘀质 | 阳虚质 | 阴虚质 | 有 | 无 | |
训练集 | 258(22.89) | 26(2.31) | 106(9.41) | 45(3.99) | 10(0.89) | 249(22.09) | 109(9.67) | 171(15.17) | 153(13.58) | 178(15.79) | 949(84.21) |
验证集 | 61(20.96) | 7(2.41) | 30(10.31) | 9(3.09) | 4(1.38) | 62(21.31) | 20(6.87) | 56(19.24) | 42(14.43) | 48(16.50) | 243(83.50) |
χ2值 | 6.21 | 0.09 | |||||||||
P值 | 0.623 | 0.771 |
Table 1 Comparison of general conditions between training set and validation set
组别 | 例数 | 性别(男/女) | 年龄 | 吸烟史 | ASCVD家族史 | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|
65~69岁 | 70~74岁 | 75~79岁 | ≥80岁 | 有 | 无 | 有 | 无 | ||||
训练集 | 1 127 | 503/624 | 465(41.26) | 321(28.48) | 188(16.68) | 153(13.58) | 635(56.34) | 492(43.66) | 320(28.39) | 807(71.61) | |
验证集 | 291 | 138/153 | 129(44.33) | 65(22.34) | 56(19.24) | 41(14.09) | 166(57.05) | 125(42.96) | 89(30.58) | 202(69.42) | |
χ2值 | 0.73 | 4.66 | 0.05 | 0.54 | |||||||
P值 | 0.394 | 0.199 | 0.830 | 0.462 | |||||||
组别 | 糖尿病史 | 收缩压 | 高血压用药史 | 腰围 | |||||||
有 | 无 | <140 mmHg | ≥140 mmHg | 有 | 无 | 正常水平(男性<85 cm/女性<80 cm) | 升高(男性≥85 cm/女性≥80 cm) | ||||
训练集 | 344(30.52) | 783(69.48) | 737(65.39) | 390(34.61) | 633(56.17) | 494(43.83) | 251(22.27) | 876(77.73) | |||
验证集 | 84(28.87) | 207(71.13) | 188(64.61) | 103(35.39) | 167(57.39) | 124(42.61) | 65(22.34) | 226(77.66) | |||
χ2值 | 0.30 | 0.06 | 0.14 | 0.00 | |||||||
P值 | 0.583 | 0.801 | 0.708 | 0.981 | |||||||
组别 | BMI | TC | TG | ||||||||
低体质量(<18.5 kg/m2) | 正常体质量(18.5~23.9 kg/m2) | 超重(24.0~27.9 kg/m2) | 肥胖(≥28.0 kg/m2) | 合适水平(<5.2 mmol/L) | 边缘升高(5.2~<6.2 mmol/L) | 升高(≥6.2 mmol/L) | 合适水平(<1.7 mmol/L) | 边缘升高(1.7~<2.3 mmol/L) | 升高(≥2.3 mmol/L) | ||
训练集 | 377(33.45) | 443(39.31) | 297(26.35) | 10(0.89) | 589(52.26) | 391(34.69) | 147(13.04) | 756(67.08) | 206(18.28) | 165(14.64) | |
验证集 | 89(30.58) | 132(45.36) | 66(22.68) | 4(1.38) | 146(50.17) | 113(38.83) | 32(11.00) | 191(65.64) | 55(18.90) | 45(15.46) | |
χ2值 | 4.44 | 2.08 | 0.23 | ||||||||
P值 | 0.217 | 0.354 | 0.893 | ||||||||
组别 | 体质类型 | ASCVD事件 | |||||||||
平和质 | 气虚质 | 气郁质 | 湿热质 | 特禀质 | 痰湿质 | 血瘀质 | 阳虚质 | 阴虚质 | 有 | 无 | |
训练集 | 258(22.89) | 26(2.31) | 106(9.41) | 45(3.99) | 10(0.89) | 249(22.09) | 109(9.67) | 171(15.17) | 153(13.58) | 178(15.79) | 949(84.21) |
验证集 | 61(20.96) | 7(2.41) | 30(10.31) | 9(3.09) | 4(1.38) | 62(21.31) | 20(6.87) | 56(19.24) | 42(14.43) | 48(16.50) | 243(83.50) |
χ2值 | 6.21 | 0.09 | |||||||||
P值 | 0.623 | 0.771 |
变量 | β | SE | Wald χ2值 | OR(95%CI) | P值 |
---|---|---|---|---|---|
性别(以女为参照) | |||||
男 | 0.744 | 0.167 | 19.942 | 2.105(1.522~2.926) | <0.001 |
年龄(以65~69岁为参照) | |||||
70~74岁 | 0.471 | 0.219 | 4.652 | 1.602(1.043~2.463) | 0.031 |
75~79岁 | 1.250 | 0.223 | 31.302 | 3.492(2.255~5.426) | <0.001 |
≥80岁 | 0.732 | 0.257 | 8.100 | 2.080(1.246~3.427) | 0.004 |
BMI(以未超重为参照a) | |||||
超重 | 0.397 | 0.206 | 3.722 | 1.488(0.998~2.241) | 0.054 |
肥胖 | 0.741 | 0.214 | 12.003 | 2.099(1.384~3.208) | 0.001 |
糖尿病史 | 0.114 | 0.175 | 0.423 | 1.120(0.791~1.572) | 0.515 |
ASCVD家族史 | 0.507 | 0.171 | 8.770 | 1.661(1.183~2.317) | 0.003 |
高血压用药史 | 0.165 | 0.166 | 0.982 | 1.179(0.853~1.637) | 0.322 |
收缩压×高血压用药史 | 1.560 | 0.190 | 67.667 | 4.757(3.275~6.893) | <0.001 |
收缩压升高 | 1.069 | 0.167 | 41.150 | 2.913(2.104~4.048) | <0.001 |
吸烟史 | 0.074 | 0.165 | 0.199 | 1.076(0.780~1.492) | 0.656 |
TC(以参考范围为参照) | |||||
边缘升高 | 0.391 | 0.186 | 4.408 | 1.478(1.025~2.130) | 0.036 |
升高 | 1.120 | 0.222 | 25.566 | 3.066(1.977~4.721) | <0.001 |
TG(以参考范围为参照) | |||||
边缘升高 | 0.464 | 0.197 | 5.544 | 1.590(1.073~2.327) | 0.019 |
升高 | -0.242 | 0.259 | 0.872 | 0.785(0.460~1.279) | 0.350 |
腰围升高 | 1.538 | 0.308 | 24.922 | 4.657(2.654~8.975) | <0.001 |
体质类型(以平和质为参照) | |||||
阳虚质 | 0.223 | 0.312 | 0.510 | 1.249(0.673~2.297) | 0.475 |
阴虚质 | 1.046 | 0.280 | 13.951 | 2.846(1.651~4.971) | <0.001 |
痰湿质 | 1.041 | 0.254 | 16.749 | 2.833(1.738~4.729) | <0.001 |
血瘀质 | 0.814 | 0.316 | 6.641 | 2.256(1.208~4.190) | 0.010 |
气郁质 | -1.050 | 0.550 | 3.644 | 0.350(0.101~0.927) | 0.056 |
其他b | -0.022 | 0.426 | 0.003 | 0.978(0.399~2.166) | 0.958 |
Table 2 Univariate Logistic regression analysis of ASCVD events
变量 | β | SE | Wald χ2值 | OR(95%CI) | P值 |
---|---|---|---|---|---|
性别(以女为参照) | |||||
男 | 0.744 | 0.167 | 19.942 | 2.105(1.522~2.926) | <0.001 |
年龄(以65~69岁为参照) | |||||
70~74岁 | 0.471 | 0.219 | 4.652 | 1.602(1.043~2.463) | 0.031 |
75~79岁 | 1.250 | 0.223 | 31.302 | 3.492(2.255~5.426) | <0.001 |
≥80岁 | 0.732 | 0.257 | 8.100 | 2.080(1.246~3.427) | 0.004 |
BMI(以未超重为参照a) | |||||
超重 | 0.397 | 0.206 | 3.722 | 1.488(0.998~2.241) | 0.054 |
肥胖 | 0.741 | 0.214 | 12.003 | 2.099(1.384~3.208) | 0.001 |
糖尿病史 | 0.114 | 0.175 | 0.423 | 1.120(0.791~1.572) | 0.515 |
ASCVD家族史 | 0.507 | 0.171 | 8.770 | 1.661(1.183~2.317) | 0.003 |
高血压用药史 | 0.165 | 0.166 | 0.982 | 1.179(0.853~1.637) | 0.322 |
收缩压×高血压用药史 | 1.560 | 0.190 | 67.667 | 4.757(3.275~6.893) | <0.001 |
收缩压升高 | 1.069 | 0.167 | 41.150 | 2.913(2.104~4.048) | <0.001 |
吸烟史 | 0.074 | 0.165 | 0.199 | 1.076(0.780~1.492) | 0.656 |
TC(以参考范围为参照) | |||||
边缘升高 | 0.391 | 0.186 | 4.408 | 1.478(1.025~2.130) | 0.036 |
升高 | 1.120 | 0.222 | 25.566 | 3.066(1.977~4.721) | <0.001 |
TG(以参考范围为参照) | |||||
边缘升高 | 0.464 | 0.197 | 5.544 | 1.590(1.073~2.327) | 0.019 |
升高 | -0.242 | 0.259 | 0.872 | 0.785(0.460~1.279) | 0.350 |
腰围升高 | 1.538 | 0.308 | 24.922 | 4.657(2.654~8.975) | <0.001 |
体质类型(以平和质为参照) | |||||
阳虚质 | 0.223 | 0.312 | 0.510 | 1.249(0.673~2.297) | 0.475 |
阴虚质 | 1.046 | 0.280 | 13.951 | 2.846(1.651~4.971) | <0.001 |
痰湿质 | 1.041 | 0.254 | 16.749 | 2.833(1.738~4.729) | <0.001 |
血瘀质 | 0.814 | 0.316 | 6.641 | 2.256(1.208~4.190) | 0.010 |
气郁质 | -1.050 | 0.550 | 3.644 | 0.350(0.101~0.927) | 0.056 |
其他b | -0.022 | 0.426 | 0.003 | 0.978(0.399~2.166) | 0.958 |
变量 | 模型1 | 模型2 | ||
---|---|---|---|---|
OR(95%CI) | P值 | OR(95%CI) | P值 | |
性别(以女为参照) | ||||
男 | 3.368(2.298~4.936) | <0.001 | 3.145(2.114~4.677) | <0.001 |
年龄(以65~69岁为参照) | ||||
70~74岁 | 1.613(1.012~2.57) | 0.044 | 1.547(0.959~2.495) | 0.074 |
75~79岁 | 2.845(1.748~4.632) | <0.001 | 2.882(1.737~4.779) | <0.001 |
≥80岁 | 1.002(0.555~1.81) | 0.994 | 1.130(0.618~2.064) | 0.692 |
BMI(以未超重为参照a) | ||||
超重 | 0.902(0.559~1.454) | 0.671 | 0.902(0.552~1.475) | 0.682 |
肥胖 | 1.666(1.000~2.776) | 0.050 | 1.690(0.998~2.863) | 0.051 |
腰围升高 | 5.910(2.920~11.964) | <0.001 | 6.094(2.962~12.537) | <0.001 |
收缩压升高 | 2.337(1.468~3.723) | <0.001 | 2.291(1.423~3.689) | 0.001 |
TC(以参考范围为参照) | ||||
边缘升高 | 1.771(1.171~2.679) | 0.007 | 1.798(1.178~2.744) | 0.007 |
升高 | 3.959(2.385~6.572) | <0.001 | 3.609(2.144~6.074) | <0.001 |
收缩压×高血压用药史 | 3.269(1.915~5.579) | <0.001 | 3.505(2.021~6.078) | <0.001 |
体质类型(以平和质为参照) | ||||
阳虚质 | 1.200(0.607~2.373) | 0.601 | ||
阴虚质 | 2.679(1.438~4.993) | 0.002 | ||
痰湿质 | 3.067(1.750~5.374) | <0.001 | ||
血瘀质 | 2.530(1.276~5.014) | 0.008 | ||
气郁质 | 0.418(0.136~1.285) | 0.128 | ||
其他b | 1.010(0.408~2.500) | 0.982 |
Table 3 Multivariate Logistic regression analysis of ASCVD events
变量 | 模型1 | 模型2 | ||
---|---|---|---|---|
OR(95%CI) | P值 | OR(95%CI) | P值 | |
性别(以女为参照) | ||||
男 | 3.368(2.298~4.936) | <0.001 | 3.145(2.114~4.677) | <0.001 |
年龄(以65~69岁为参照) | ||||
70~74岁 | 1.613(1.012~2.57) | 0.044 | 1.547(0.959~2.495) | 0.074 |
75~79岁 | 2.845(1.748~4.632) | <0.001 | 2.882(1.737~4.779) | <0.001 |
≥80岁 | 1.002(0.555~1.81) | 0.994 | 1.130(0.618~2.064) | 0.692 |
BMI(以未超重为参照a) | ||||
超重 | 0.902(0.559~1.454) | 0.671 | 0.902(0.552~1.475) | 0.682 |
肥胖 | 1.666(1.000~2.776) | 0.050 | 1.690(0.998~2.863) | 0.051 |
腰围升高 | 5.910(2.920~11.964) | <0.001 | 6.094(2.962~12.537) | <0.001 |
收缩压升高 | 2.337(1.468~3.723) | <0.001 | 2.291(1.423~3.689) | 0.001 |
TC(以参考范围为参照) | ||||
边缘升高 | 1.771(1.171~2.679) | 0.007 | 1.798(1.178~2.744) | 0.007 |
升高 | 3.959(2.385~6.572) | <0.001 | 3.609(2.144~6.074) | <0.001 |
收缩压×高血压用药史 | 3.269(1.915~5.579) | <0.001 | 3.505(2.021~6.078) | <0.001 |
体质类型(以平和质为参照) | ||||
阳虚质 | 1.200(0.607~2.373) | 0.601 | ||
阴虚质 | 2.679(1.438~4.993) | 0.002 | ||
痰湿质 | 3.067(1.750~5.374) | <0.001 | ||
血瘀质 | 2.530(1.276~5.014) | 0.008 | ||
气郁质 | 0.418(0.136~1.285) | 0.128 | ||
其他b | 1.010(0.408~2.500) | 0.982 |
变量 | AUC | 95%CI | P值 | 最佳截断值 | 灵敏度(%) | 特异度(%) |
---|---|---|---|---|---|---|
模型2 | 0.818 | 0.787~0.848 | <0.001 | 0.194 | 67.70 | 80.83 |
模型1 | 0.796 | 0.766~0.830 | <0.001 | 0.163 | 74.34 | 75.76 |
Table 4 AUC,optimal cutoff value,sensitivity,and specificity of Model 1 and Model 2 for predicting ASCVD events
变量 | AUC | 95%CI | P值 | 最佳截断值 | 灵敏度(%) | 特异度(%) |
---|---|---|---|---|---|---|
模型2 | 0.818 | 0.787~0.848 | <0.001 | 0.194 | 67.70 | 80.83 |
模型1 | 0.796 | 0.766~0.830 | <0.001 | 0.163 | 74.34 | 75.76 |
[1] |
GBD Diseases and Injuries Collaborators. Global burden of 369 diseases and injuries in 204 countries and territories,1990-2019:a systematic analysis for the Global Burden of Disease Study 2019[J]. Lancet,2020,396(10258):1204-1222. DOI:10.1016/S0140-6736(20)30925-9.
|
[2] |
向祥龙,王琦琦,李俊琦,等. 2009—2019年中国心脑血管疾病死亡率趋势分析[J]. 中国预防医学杂志,2021,22(11):811-818. DOI:10.16506/j.1009-6639.2021.11.001.
|
[3] |
中华医学会全科医学分会慢病管理专业学组. 中国成人动脉粥样硬化性心血管疾病基层管理路径专家共识(建议稿)[J]. 中国全科医学,2017,20(3):251-261. DOI:10.3969/j.issn.1007-9572.2017.03.001.
|
[4] |
|
[5] |
谷鸿秋,周支瑞,章仲恒,等. 临床预测模型:基本概念、应用场景及研究思路[J]. 中国循证心血管医学杂志,2018,10(12):1454-1456,1462. DOI:10.3969/j.issn.1674-4055.2018.12.04.
|
[6] |
白明华,王济,郑燕飞,等. 基于108015例样本数据的中国人群中医体质类型分布特征分析[J]. 北京中医药大学学报,2020,43(6):498-507. DOI:10.3969/j.issn.1006-2157.2020.06.010.
|
[7] |
谢琴,何华琴. 不同中医体质人群心血管病危险因素调查分析[J]. 中医药管理杂志,2021,29(5):48-49. DOI:10.16690/j.cnki.1007-9203.2021.05.020.
|
[8] |
王思佳,张哲. 基于冠状动脉粥样硬化性心脏病与中医体质的相关性探讨防治策略[J]. 实用中医内科杂志,2022,36(5):70-72. DOI:10.13729/j.issn.1671-7813.Z20211288.
|
[9] | |
[10] |
刘冬桂,王晓蕾,杨丽花,等. 中医体质综合干预在高尿酸血症患者心血管疾病预防中的应用价值[J]. 中国当代医药,2019,26(22):41-44. DOI:10.3969/j.issn.1674-4721.2019.22.012.
|
[11] |
黄钜明. "辨质论治"结合慢病管理干预动脉粥样硬化的临床疗效分析[D]. 广州:广州中医药大学,2016.
|
[12] |
北京高血压防治协会,北京糖尿病防治协会,北京慢性病防治与健康教育研究会,等. 基层心血管病综合管理实践指南2020[J]. 中国医学前沿杂志(电子版),2020,12(8):1-73. DOI:10.12037/YXQY.2020.08-01.
|
[13] |
|
[14] |
|
[15] | |
[16] |
|
[17] |
|
[18] |
韩泽森,来利红. 冠状动脉粥样硬化性心脏病临床预测模型研究现状概述[J]. 心血管病学进展,2020,41(6):638-641.
|
[19] |
|
[20] |
吴锡桂,赖声汉,高红,等. 首都钢铁公司988名男性工人冠心病危险因素的多元分析[J]. 中华心血管病杂志,1983,11(1):28-32.
|
[21] |
|
[22] |
|
[23] |
|
[24] |
|
[25] |
|
[26] |
|
[27] |
|
[28] |
|
[29] |
文玲子,王俊峰,谷鸿秋. 临床预测模型:新预测因子的预测增量值[J]. 中国循证心血管医学杂志,2020,12(6):655-659. DOI:10.3969/j.issn.1674-4055.2020.06.04.
|
[30] |
|
[31] |
|
[1] | ZHOU Qibao, LUO Xiao, CHEN Ling, CAO Junda, LI Juxiang, XU Jinsong, SU Hai. Clinical Study on the Diagnostic Value of Circadian Variability of Systolic Blood Pressure Combined with SDNN in Coronary Heart Disease [J]. Chinese General Practice, 2025, 28(30): 3760-3765. |
[2] | WU Wenjun, WEI Jingjing, LI Xue, REN Hongjie, YU Rui, PENG Guangcao, ZHU Mingjun. Regularity of Prescriptions for Coronary Heart Disease with Hypertension Based on Latent Structure and Association Rules [J]. Chinese General Practice, 2025, 28(30): 3787-3795. |
[3] | XU Jialan, YAN Hong, WEN Jun, ZHOU Zitong, WANG Siyu. Prevalence of Potentially Inappropriate Medication in Older Adults with Cancer: a Meta-analysis [J]. Chinese General Practice, 2025, 28(30): 3815-3822. |
[4] | LI Ling, LI Yaping, QIAN Shixing, NIE Jing, LU Chunhua, LI Xia. Research on Influencing Factors and Risk Prediction of Cognitive Function in Community-dwelling Middle-aged and Elderly People [J]. Chinese General Practice, 2025, 28(30): 3773-3778. |
[5] | XIANG Xinyue, ZHANG Bingqing, OUYANG Yuqin, TANG Wenjuan, FENG Wenhuan. Impact of Short-term Medical Weight Loss on Atherosclerotic Cardiovascular Disease Risk in Patients with Obesity [J]. Chinese General Practice, 2025, 28(26): 3229-3239. |
[6] | YU Wenhua, LI Jianguo, DUAN Wenyan, GAO Xuyan, LI Xiaxia, ZHANG Zilong, ZHANG Li, MA Lina. Reliability and Validity of the Function Impairment Screening Tool among Community-dwelling Older Adults [J]. Chinese General Practice, 2025, 28(24): 3000-3004. |
[7] | YANG Chen, CHEN Tong, ZHANG Lifang, ZHANG Hongxu, LI Pengfei, ZHANG Xuejuan. Prognostic Impact of Dapagliflozin in Elderly Breast Cancer Survivors with Heart Failure with Preserved Ejection Fraction and Type 2 Diabetes [J]. Chinese General Practice, 2025, 28(24): 3053-3058. |
[8] | LI Jiaxin, LIU Zhonghui, XIE Shuo, FU Zhifang, SUN Dan, JIAO Hongmei. Trajectory in Biomarkers of Metabolic and Inflammatory States as Early Predictors of Chronic Critical Illness in Aging Patients [J]. Chinese General Practice, 2025, 28(24): 2993-2999. |
[9] | YANG Ji, ZHANG Yao, ZHAO Yingqiang, ZHANG Qiuyue. Evaluation of the Effectiveness of TCM Three-level Prevention and Control Model in the Management of Patients with Coronary Heart Disease and Stroke: a Single-center, Prospective Cohort Study [J]. Chinese General Practice, 2025, 28(22): 2750-2761. |
[10] | ZHAO Xiaoqing, GUO Tongtong, ZHANG Xinyi, LI Linhong, ZHANG Ya, JI Lihong, DONG Zhiwei, GAO Qianqian, CAI Weiqing, ZHENG Wengui, JING Qi. Construction and Validation of a Risk Prediction Model for Cognitive Impairment in Community-dwelling Older Adults [J]. Chinese General Practice, 2025, 28(22): 2776-2783. |
[11] | SHI Xiaotian, WANG Shan, YANG Huayu, YANG Yifan, LI Xu, MA Qing. Association between Body Mass Index and Mortality among Older Chinese: a Cohort Study [J]. Chinese General Practice, 2025, 28(22): 2791-2797. |
[12] | LIU Meixia, YIN Jinnian, WU Mei, YANG Xing, ZHOU Quanxiang, YANG Jingyuan. Impact of Body Mass Index on the Association of Triglyceride Glucose Index with Cognitive Function: a Cross-sectional Study in Rural Older Adults in Guizhou Province [J]. Chinese General Practice, 2025, 28(22): 2806-2812. |
[13] | GAO Haijun, REN Jiayu, WANG Ruolin, ZHOU Huiya, QU Peng. Research Progress on the Role of Endothelial Cell Injury and Dysfunction in Atherosclerosis [J]. Chinese General Practice, 2025, 28(21): 2697-2704. |
[14] | HAO Aihua, ZENG Ziying, JIN Aiqiong, TANG Lingling, ZHENG Zique, MA Jingtai, ZHAO Jianguo, ZENG Weilin, XIAO Jianpeng, NIE Hui, YANG Ying. Analysis of Factors Influencing Avoidable Hospitalization for Elderly Hypertensive Patients [J]. Chinese General Practice, 2025, 28(19): 2370-2375. |
[15] | CHU Tianyu, GU Yan. Carotid Artery Calcification Features in Plaque Stability and Clinical Events [J]. Chinese General Practice, 2025, 28(18): 2247-2252. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||